Manufacturer Commercial Supply with High Purity and Stable Quality
Chemical Name: Deslorelin Acetate
Sequences: Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt
CAS: 57773-65-6
API High Quality, Commercial Production
| Chemical Name | Deslorelin Acetate |
| Sequences | Pyr-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-NHEt |
| CAS Number | 57773-65-6 |
| CAT Number | RF-API16 |
| Stock Status | In Stock, Production Scale Up to Kilograms |
| Molecular Formula | C64H83N17O12 |
| Molecular Weight | 1282.48 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | White Powder or Almost White Powder |
| Identity by HPLC | The retention is same with the reference substance |
| Amino Acid Composition | Glu: 0.85～1.10 |
| Pro: 0.85～1.10 | |
| Leu: 0.90～1.10 | |
| Tyr: 0.85～1.10 | |
| His: 0.85～1.10 | |
| Arg: 0.85～1.10 | |
| Ser: Present | |
| Trp: Present | |
| Purity (By HPLC) | ≥98.0% (By Area Integration) |
| Related Substance(By HPLC) | Total Impurities ≤2.0% |
| Largest Single Impurity ≤1.0% | |
| Acetate Content (By HPLC) | ≤12.0% |
| Water Content (Karl Fischer) | ≤8.0% |
| Peptide Content (N%) | ≥80.0% |
| Bacterial Endotoxins | ≤70 IU/mg |
| Residual Organic Solvents | Acetonitrile ≤0.041% (By GC) |
| DMF ≤0.088% (By GC) | |
| MEOH ≤0.3% (By GC) | |
| TFA ≤0.1% (By HPLC) | |
| Assay | 95%~105% (By Anhydrous, Acetic Acid-free) |
| Test Standard | Enterprise Standard |
| Origin of Product | Synthetic |
| Storage Conditions | -20°C Freezer. Keep Package Close When Not In Use. |
| Shipping Requirements | Ice Bags, Desiccant Bags |
| Attention | Only for Research, Not for Human Use |
| Usage | Active Pharmaceutical Ingredient (API) |
Package: Bottle, Vials, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Deslorelin acetate is a gonadotropin releasing hormone super-agonist. In is used in veterinary medicine to induce ovulation and to stabilize high-risk pregnancies. Deslorelin is a synthetic nonapeptide analogue of the natural gonadotrophin releasing hormone super-agonist (GnRH agonist) with potential antineoplastic activity. It binds to and activates pituitary gonadotropin releasing hormone (GnRH) receptors. It stops the production of sex hormones. It is currently used to induce ovulation in mares as part of the artificial insemination process. It is also used to stabilize high-risk pregnancies, mainly of livestock and is also used to treat benign prostate hyperplasia in dogs. It is manufactured by Thorne BioScience LLC and was introduced to the USA market following the withdrawal of Ovuplant. It has been listed. D'eslorelin is being studied in the treatment of cancer as a way to block sex hormones made by the ovaries or testicles. It belongs to the family of drugs called gonad-releasing hormone analogs. It is used for the induction of ovulation in mares. D'eslorelin binds to and activates pituitary gona releasing hormone (GnRH) receptors. Continuous, prolonged administration of gose in males results in pituitary GnRH receptor desensitization and inhibition of pituitary secretion of follicle stimulating hormone (FSH) and (LH), leading to a significant decline in test production; in females, prolonged administration results in a decrease in estradiol production.